No augmentation of indoleamine 2,3-dioxygenase (IDO) activity through belatacept treatment in liver transplant recipients.
Clin Exp Immunol
; 192(2): 233-241, 2018 05.
Article
in En
| MEDLINE
| ID: mdl-29271486
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Liver Transplantation
/
Indoleamine-Pyrrole 2,3,-Dioxygenase
/
Abatacept
/
Immunosuppressive Agents
Type of study:
Clinical_trials
/
Guideline
/
Observational_studies
/
Risk_factors_studies
Limits:
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Clin Exp Immunol
Year:
2018
Document type:
Article
Affiliation country: